Partially HLA Mismatched (Haploidentical) Allogeneic Bone Marrow Transplantation

NCT01749293 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped The protocol design is being reconfigured in order to open a new study.

Conditions

Hematologic Malignancies

Interventions

PROCEDURE: Haploidentical Transplant
DRUG: Fludarabine
DRUG: Busulfan
RADIATION: Total Body Irradiation
DRUG: Cyclophosphamide

Sponsor

University of Illinois at Chicago